Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets : The S & P 500 briefly touched 6,000 as the rally to record highs continued. It's the fourth positive session in a row for the broad-based index, which is up nearly 4% since the presidential election.
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.
LILLY DRN Home Depot Inc Walt Disney Co Shopify Inc Tyson Foods Inc Astrazeneca PLC Astrazeneca PLC Shopify Inc Occidental Petroleum Corp Cisco Systems Inc Advance Auto Parts Inc Applied Materials Inc Alibaba Group Holding Ltd Spotify Technology SA Costco Wholesale Corp Arista Networks Inc Tesla Inc S&P 500 Index Jim Cramer Investment Strategy Markets Breaking News: Markets Homestretch Business News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidanceSkyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Read more »
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidanceSkyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Read more »
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidanceSkyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Read more »
Eli Lilly Takes Aim at Compounded GLP-1 Medications With Cease-and-Desist LettersEli Lilly has issued cease-and-desist letters to several companies selling compounded versions of its diabetes drug Mounjaro and weight loss medication Zepbound, citing deceptive advertising practices.
Read more »
Eli Lilly to trial use of weight loss drugs to combat unemployment in UKU.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.
Read more »
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patientsEli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
Read more »